When Roy Vagelos was forced to retire in 1994 as chief executive officer of Merck & Co. at the mandatory age of 65, he feared boredom. So he joined Regeneron Pharmaceuticals Inc.’s board, a move that would make him a billionaire.

Sourced through Scoop.it from: www.bloomberg.com

See on Scoop.it – Public-Private Duality, Economic Crisis, and New Financial Trends